Krystal Biotech, Inc.
KRYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $89,159 | $10,932 | -$139,975 | -$69,570 |
| Dep. & Amort. | $6,714 | $5,007 | $4,055 | $2,769 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $49,127 | $39,933 | $33,230 | $15,319 |
| Change in WC | -$14,457 | -$37,882 | $2,811 | $2,052 |
| Other Non-Cash | -$7,123 | -$106,794 | -$690 | $1,492 |
| Operating Cash Flow | $123,420 | -$88,804 | -$100,569 | -$47,938 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,238 | -$11,799 | -$52,979 | -$68,336 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$457,740 | -$508,776 | -$318,781 | -$190,462 |
| Inv. Sales/Matur. | $298,539 | $503,213 | $257,677 | $32,028 |
| Other Inv. Act. | $0 | $100,000 | $0 | $0 |
| Investing Cash Flow | -$163,439 | $82,638 | -$114,083 | -$226,770 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $32,400 | $203,499 | $35,996 | $355,645 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,386 | -$749 | -$649 | -$7,960 |
| Financing Cash Flow | $27,014 | $202,750 | $35,347 | $347,685 |
| Forex Effect | -$458 | -$156 | -$41 | $0 |
| Net Chg. in Cash | -$13,463 | $196,428 | -$179,346 | $72,977 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $358,328 | $161,900 | $341,246 | $268,269 |
| End Cash | $344,865 | $358,328 | $161,900 | $341,246 |
| Free Cash Flow | $119,182 | -$100,603 | -$153,548 | -$116,274 |